Dominari (DOMH) Stock Price, News & Analysis

Company Overview

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Key Stats

• Today's Range: $1.53 to $1.56
• 50-Day Range: $1.56 to $2.08
• 52-Week Range: $1.50 to $3.20
• Volume: 1,404 shs
• Average Volume: 10,642 shs
• Market Capitalization: $9.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DOMH Stock Analysis - Frequently Asked Questions

How have DOMH shares performed this year?

Dominari's stock was trading at $2.59 at the start of the year. Since then, DOMH shares have decreased by 39.4% and is now trading at $1.57.
View the best growth stocks for 2024 here.

How were Dominari's earnings last quarter?

Dominari Holdings Inc. (NASDAQ:DOMH) announced its earnings results on Friday, November, 8th. The company reported ($0.45) earnings per share for the quarter. The firm had revenue of $4.04 million for the quarter. Dominari had a negative net margin of 180.22% and a negative trailing twelve-month return on equity of 32.89%.

How do I buy shares of Dominari?

Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Dominari own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dominari investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Crescent Point Energy (CPG), DatChat (DATS), Infinera (INFN), Kroger (KR) and KraneShares CSI China Internet ETF (KWEB).

Company Calendar

• Last Earnings: 11/08/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 4/07/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Security brokers & dealers
• Sub-Industry: Trading
• Current Symbol: NASDAQ:DOMH
• CUSIP: N/A
• CIK: 12239
• Web: N/A
• Phone: (112) 745-1374
• Fax: 703-992-9348
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.87)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-22,880,000.00
• Net Margins: -180.22%
• Pretax Margin: -180.22%
• Return on Equity: -32.89%
• Return on Assets: -29.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 10.25
• Quick Ratio: 10.25

Sales & Book Value

• Annual Sales: $12.59 million
• Price / Sales: 0.78
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.90 per share
• Price / Book: 0.16

Miscellaneous

• Outstanding Shares: 6,276,000
• Free Float: 3,971,000
• Market Cap: $9.85 million
• Optionable: Not Optionable
• Beta: 0.96